All Pharma News
price-trendAsk Us
Indapta Therapeutics Receives U.S. FDA Fast Track Designation for IDP-023

Indapta Therapeutics Receives U.S. FDA Fast Track Designation for IDP-023
BUSINESSWIRE
29 Feb 2024
Share Share
Indapta Therapeutics Announces First Patients Treated with IDP-023

Indapta Therapeutics Announces First Patients Treated with IDP-023
BUSINESSWIRE
11 Jan 2024
Share Share
Indapta plans Phase I trial of NK Cell therapy

Indapta plans Phase I trial of NK Cell therapy
CLINICAL TRIALS ARENA
17 May 2023
Share Share
Indapta Therapeutics Names Moya Daniels, Senior Vice President

Indapta Therapeutics Names Moya Daniels, Senior Vice President
BUSINESSWIRE
17 Jan 2023
Share Share